Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Gastric Inhibitory Polypeptide Receptor market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Gastric Inhibitory Polypeptide Receptor are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Gastric Inhibitory Polypeptide Receptor market segmented into
HM-15211
LBT-6030
LY-3298176
NNC-92041706
Others

Based on the end-use, the global Gastric Inhibitory Polypeptide Receptor market classified into
Metabolic Disorder
Type 2 Diabetes
Obesity
Others

Based on geography, the global Gastric Inhibitory Polypeptide Receptor market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Alchemia Limited
AstraZeneca Plc
Carmot Therapeutics, Inc.
Diabetica Limited
Longevity Biotech, Inc
Novo Nordisk A/S
Sanofi
Zealand Pharma A/S

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR INDUSTRY
2.1 Summary about Gastric Inhibitory Polypeptide Receptor Industry
2.2 Gastric Inhibitory Polypeptide Receptor Market Trends
2.2.1 Gastric Inhibitory Polypeptide Receptor Production & Consumption Trends
2.2.2 Gastric Inhibitory Polypeptide Receptor Demand Structure Trends
2.3 Gastric Inhibitory Polypeptide Receptor Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 HM-15211
4.2.2 LBT-6030
4.2.3 LY-3298176
4.2.4 NNC-92041706
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Metabolic Disorder
4.3.2 Type 2 Diabetes
4.3.3 Obesity
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 HM-15211
5.2.2 LBT-6030
5.2.3 LY-3298176
5.2.4 NNC-92041706
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Metabolic Disorder
5.3.2 Type 2 Diabetes
5.3.3 Obesity
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 HM-15211
6.2.2 LBT-6030
6.2.3 LY-3298176
6.2.4 NNC-92041706
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Metabolic Disorder
6.3.2 Type 2 Diabetes
6.3.3 Obesity
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 HM-15211
7.2.2 LBT-6030
7.2.3 LY-3298176
7.2.4 NNC-92041706
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Metabolic Disorder
7.3.2 Type 2 Diabetes
7.3.3 Obesity
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 HM-15211
8.2.2 LBT-6030
8.2.3 LY-3298176
8.2.4 NNC-92041706
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Metabolic Disorder
8.3.2 Type 2 Diabetes
8.3.3 Obesity
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 HM-15211
9.2.2 LBT-6030
9.2.3 LY-3298176
9.2.4 NNC-92041706
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Metabolic Disorder
9.3.2 Type 2 Diabetes
9.3.3 Obesity
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Alchemia Limited
10.1.2 AstraZeneca Plc
10.1.3 Carmot Therapeutics, Inc.
10.1.4 Diabetica Limited
10.1.5 Longevity Biotech, Inc
10.1.6 Novo Nordisk A/S
10.1.7 Sanofi
10.1.8 Zealand Pharma A/S
10.2 Gastric Inhibitory Polypeptide Receptor Sales Date of Major Players (2017-2020e)
10.2.1 Alchemia Limited
10.2.2 AstraZeneca Plc
10.2.3 Carmot Therapeutics, Inc.
10.2.4 Diabetica Limited
10.2.5 Longevity Biotech, Inc
10.2.6 Novo Nordisk A/S
10.2.7 Sanofi
10.2.8 Zealand Pharma A/S
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Gastric Inhibitory Polypeptide Receptor Product Type Overview
2.Table Gastric Inhibitory Polypeptide Receptor Product Type Market Share List
3.Table Gastric Inhibitory Polypeptide Receptor Product Type of Major Players
4.Table Brief Introduction of Alchemia Limited
5.Table Brief Introduction of AstraZeneca Plc
6.Table Brief Introduction of Carmot Therapeutics, Inc.
7.Table Brief Introduction of Diabetica Limited
8.Table Brief Introduction of Longevity Biotech, Inc
9.Table Brief Introduction of Novo Nordisk A/S
10.Table Brief Introduction of Sanofi
11.Table Brief Introduction of Zealand Pharma A/S
12.Table Products & Services of Alchemia Limited
13.Table Products & Services of AstraZeneca Plc
14.Table Products & Services of Carmot Therapeutics, Inc.
15.Table Products & Services of Diabetica Limited
16.Table Products & Services of Longevity Biotech, Inc
17.Table Products & Services of Novo Nordisk A/S
18.Table Products & Services of Sanofi
19.Table Products & Services of Zealand Pharma A/S
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Gastric Inhibitory Polypeptide Receptor Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Gastric Inhibitory Polypeptide Receptor Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Gastric Inhibitory Polypeptide Receptor Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Gastric Inhibitory Polypeptide Receptor Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Gastric Inhibitory Polypeptide Receptor Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Gastric Inhibitory Polypeptide Receptor Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Gastric Inhibitory Polypeptide Receptor Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Gastric Inhibitory Polypeptide Receptor Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure HM-15211 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure LBT-6030 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure LY-3298176 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure NNC-92041706 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Metabolic Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Type 2 Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Obesity Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure HM-15211 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure LBT-6030 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure LY-3298176 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure NNC-92041706 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Metabolic Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Type 2 Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Obesity Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure HM-15211 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure LBT-6030 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure LY-3298176 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure NNC-92041706 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Metabolic Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Type 2 Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Obesity Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure HM-15211 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure LBT-6030 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure LY-3298176 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure NNC-92041706 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Metabolic Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Type 2 Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Obesity Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure HM-15211 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure LBT-6030 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure LY-3298176 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure NNC-92041706 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Metabolic Disorder Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Type 2 Diabetes Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Obesity Segmentation Market Size

Global Immune Thrombocytopenia Drug Market (2024 Edition): Analysis By Treatment (Intravenous Immunoglobulins, Thrombopoietin Receptor Agonists, Corticosteroids, Others), By Type, By End-User, By Region: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Immune Thrombocytopenia Drug Market (2024 Edition)" which provides a complete analysis of the Global Immune Thrombocytopenia Drug industry in terms of market segmentation By Treatment (Intravenous Immunoglob...

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) ...

Executive Summary Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...

Global Branded PAH Therapeutics Market (2023 Edition) - Analysis By Drug Class (ERA, TGF-β Ligand, sGC Stimulators, IP Receptor Agonists, Others), Route of Administration, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Branded PAH Therapeutics Market (2023 Edition)" which provides a complete analysis of the Global Branded PAH Therapeutics industry in terms of market segmentation By Drug Class (Endothelin Receptor Antagonis...

2023-2028 Global and Regional G-Protein Coupled Receptor (GPCR) Targeting Industry Status and Prospects Professional Market Research Report Standard Version...

The global G-Protein Coupled Receptor (GPCR) Targeting market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help...

Global Gastric Cancer Diagnostic Procedure Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Gastric Cancer Diagnostic Procedure Market: The report discusses everything a marketer requires before investing in the global Gastric Cancer Diagnostic Procedure Market during the forecast pe...

2023-2028 Global and Regional Gastric Cancer Drugs Industry Status and Prospects Professional Market Research Report Standard Version...

The global Gastric Cancer Drugs market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...

2023-2028 Global and Regional Gastric Banding Industry Status and Prospects Professional Market Research Report Standard Version...

The global Gastric Banding market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fiel...

2023-2028 Global and Regional Triethanolamine Polypeptide Oleate Industry Status and Prospects Professional Market Research Report Standard Version...

The global Triethanolamine Polypeptide Oleate market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market p...

2023-2028 Global and Regional Chemosynthetic Polypeptide Drugs Industry Status and Prospects Professional Market Research Report Standard Version...

The global Chemosynthetic Polypeptide Drugs market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market pla...

2023-2028 Global and Regional Sphingosine 1-Phosphate Receptor (S1PR) Modulator Industry Status and Prospects Professional Market Research Report Standard Version...

The global Sphingosine 1-Phosphate Receptor (S1PR) Modulator market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which wil...